| A global reference for human genetic variation 1000 Genomes Project Consortium Nature 526 (7571), 68, 2015 | 14578* | 2015 |
| An integrated map of structural variation in 2,504 human genomes PH Sudmant, T Rausch, EJ Gardner, RE Handsaker, A Abyzov, ... Nature 526 (7571), 75-81, 2015 | 2345 | 2015 |
| Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak SK Gire, A Goba, KG Andersen, RSG Sealfon, DJ Park, L Kanneh, ... science 345 (6202), 1369-1372, 2014 | 1513 | 2014 |
| Clinical illness and outcomes in patients with Ebola in Sierra Leone JS Schieffelin, JG Shaffer, A Goba, M Gbakie, SK Gire, A Colubri, ... New England journal of medicine 371 (22), 2092-2100, 2014 | 630 | 2014 |
| Virus genomes reveal factors that spread and sustained the Ebola epidemic G Dudas, LM Carvalho, T Bedford, AJ Tatem, G Baele, NR Faria, DJ Park, ... Nature 544 (7650), 309-315, 2017 | 436 | 2017 |
| Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone DJ Park, G Dudas, S Wohl, A Goba, SLM Whitmer, KG Andersen, ... Cell 161 (7), 1516-1526, 2015 | 341 | 2015 |
| Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 J Arizti-Sanz, CA Freije, AC Stanton, BA Petros, CK Boehm, S Siddiqui, ... Nature communications 11 (1), 5921, 2020 | 306 | 2020 |
| Clinical sequencing uncovers origins and evolution of Lassa virus KG Andersen, BJ Shapiro, CB Matranga, R Sealfon, AE Lin, LM Moses, ... Cell 162 (4), 738-750, 2015 | 285 | 2015 |
| Lassa fever in post-conflict Sierra Leone JG Shaffer, DS Grant, JS Schieffelin, ML Boisen, A Goba, JN Hartnett, ... PLoS neglected tropical diseases 8 (3), e2748, 2014 | 246 | 2014 |
| Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation DA Asogun, DI Adomeh, J Ehimuan, I Odia, M Hass, M Gabriel, ... Public Library of Science 6 (9), e1839, 2012 | 205 | 2012 |
| Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus C Happi, I Adetifa, P Mbala, R Njouom, E Nakoune, A Happi, N Ndodo, ... PLoS biology 20 (8), e3001769, 2022 | 197 | 2022 |
| Reemergence of human monkeypox in Nigeria, 2017 A Yinka-Ogunleye, O Aruna, D Ogoina, N Aworabhi, W Eteng, S Badaru, ... Emerging infectious diseases 24 (6), 1149, 2018 | 197 | 2018 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ... Science 374 (6566), 423-431, 2021 | 185 | 2021 |
| Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits JE Robinson, KM Hastie, RW Cross, RE Yenni, DH Elliott, JA Rouelle, ... Nature communications 7 (1), 11544, 2016 | 177 | 2016 |
| Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018 KJ Siddle, P Eromon, KG Barnes, S Mehta, JU Oguzie, I Odia, ... New England Journal of Medicine 379 (18), 1745-1753, 2018 | 172 | 2018 |
| Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples CB Matranga, KG Andersen, S Winnicki, M Busby, AD Gladden, ... Genome biology 15, 1-12, 2014 | 166 | 2014 |
| Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine–pyrimethamine resistance in malaria-infected patients from Nigeria CT Happi, GO Gbotosho, OA Folarin, DO Akinboye, BO Yusuf, OO Ebong, ... Acta tropica 95 (3), 183-193, 2005 | 163 | 2005 |
| World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria CV Plowe, C Roper, JW Barnwell, CT Happi, HH Joshi, W Mbacham, ... Malaria journal 6, 1-10, 2007 | 154 | 2007 |
| Selection of Plasmodium falciparum Multidrug Resistance Gene 1 Alleles in Asexual Stages and Gametocytes by Artemether-Lumefantrine in Nigerian Children … CT Happi, GO Gbotosho, OA Folarin, A Sowunmi, T Hudson, M O'neil, ... Antimicrobial agents and chemotherapy 53 (3), 888-895, 2009 | 146 | 2009 |
| Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study P Okokhere, A Colubri, C Azubike, C Iruolagbe, O Osazuwa, S Tabrizi, ... The Lancet Infectious Diseases 18 (6), 684-695, 2018 | 141 | 2018 |
